Ercem Atillasoy

General Counsel at

Viracyte, Inc.

Health Technology

Consumer Services

Profile

Ercem Atillasoy is currently the Chief Regulatory & Safety Officer at Viracyte, Inc. Prior to this, he held the position of Vice President at Merck Research Laboratories Massachusetts LLC.
From 2020 to 2022, he served as the Chief Regulatory & Safety Officer at AlloVir, Inc. Dr. Atillasoy completed his undergraduate degree at City University of New York and also studied at Yale School of Medicine.

Ercem Atillasoy active positions

Companies	Position	Start
Viracyte, Inc. Viracyte, Inc. BiotechnologyHealth Technology Operates as biotechnology company	General Counsel	-

All active positions of Ercem Atillasoy

Former positions of Ercem Atillasoy

Companies	Position	End
ALLOVIRPAR	Corporate Officer/Principal	01/10/2022
Merck Research Laboratories Massachusetts LLC Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products	Corporate Officer/Principal	-

See the detail of Ercem Atillasoy's experience

Training of Ercem Atillasoy

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ercem Atillasoy's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
City University of New York City University of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Merck Research Laboratories Massachusetts LLC Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products	Health Technology
Yale School of Medicine Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AlloVir, Inc. AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections	Health Technology
Viracyte, Inc. Viracyte, Inc. BiotechnologyHealth Technology Operates as biotechnology company	Health Technology